Illumina, a San Diego-based leader in gene sequencing, announced Tuesday it has hired one of the world’s top clinical genomics experts as part of a strategy to use genetic information in clinical applications.
Garret Hampton, a Genentech executive, will join Illumina as executive vice president of clinical genomics
“This is a strategically important hire for Illumina,” said Francis deSouza, president and chief executive officer. “Garret has been on the front lines of oncology and brings deep expertise in clinical genomics to the leadership team, key to his new role leading our clinical genomics organization.”
Hampton will be responsible for leading Illumina’s clinical genomics group, including the reproductive and genetic health and oncology businesses, and regulatory, clinical and medical affairs.
Garret holds degrees from Trinity College in Dublin and University College in London.
Illumina is a global leader in DNA sequencing with products used in oncology, reproductive health, agriculture and other areas.